Citigroup boosted their EPS estimates on shares of Eli Lilly & Co. (NYSE: LLY) Other equities research analysts have also recently issued reports about the stock. Analysts at UBS AG raised their price target on shares of Eli Lilly & Co. from $51.00 to $54.00 in a research note to investors on Wednesday. They now have a ?neutral? rating on the stock. Separately, analysts at Leerink Swann reiterated an ?outperform? rating on shares of Eli Lilly & Co. in a research note to investors on Wednesday, January 23rd. Finally, analysts at TheStreet reiterated a ?buy? rating on shares of Eli Lilly & Co. in a research note to investors on Tuesday, January 22nd.
Six equities research analysts have rated the stock with a buy rating, two have assigned an overweight rating, eleven have issued a hold rating, and three have assigned a sell rating to the company. The stock presently has an average rating of ?hold? and an average target price of $53.19.
Shares of Eli Lilly & Co. traded down 0.06% during mid-day trading on Wednesday, hitting $54.29. Eli Lilly & Co. has a one year low of $38.30 and a one year high of $54.87. The stock?s 50-day moving average is currently $51.05. The company has a market cap of $60.783 billion and a P/E ratio of 14.74. Eli Lilly & Co. last issued its quarterly earnings data on Tuesday, January 29th. The company reported $0.85 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.82 by $0.03. The company had revenue of $5.96 billion for the quarter, compared to the consensus estimate of $5.78 billion. During the same quarter last year, the company posted $0.87 earnings per share. Eli Lilly & Co.?s revenue was down 1.5% compared to the same quarter last year. Eli Lilly & Co. has set its FY13 guidance at $3.82-3.97 EPS. Analysts expect that Eli Lilly & Co. will post $3.86 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, March 8th. Shareholders of record on Friday, February 15th will be given a dividend of $0.49 per share. This represents a $1.96 dividend on an annualized basis and a yield of 3.60%. The ex-dividend date of this dividend is Wednesday, February 13th.
Eli Lilly and Company discovers, develops, manufactures, and sells products, in one business segment, pharmaceutical products.